Case Study: ActoGeniX achieves secure investor communications and 30-50% lower sharing costs with IntraLinks VIA

By using Intralinks VIA®, ActoGeniX Makes Secure Connections with Investors

ActoGeniX, a Belgium‑based biopharmaceutical company developing next‑generation biological therapies for gastrointestinal, immunological and metabolic diseases, needed a more reliable way to share sensitive information with external partners and potential investors. Its existing data‑sharing tool caused recurring problems during software updates and made it hard to protect intellectual property and meet regulatory requirements.

After evaluating three offerings, ActoGeniX adopted Intralinks VIA, keeping a familiar structure for an easy migration. The company saw immediate benefits—help‑desk questions dropped, data rooms are set up faster, and access controls are simpler to manage—while costs fell an estimated 30–50% and security and dedicated support gave the team greater confidence when sharing confidential materials with investors.

ActoGeniX

Sabine Neirynck

Director of Laboratory Operations